Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma.
Wersäll PJ, Blomgren H, Pisa P, Lax I, Kälkner KM, Svedman C. Wersäll PJ, et al. Acta Oncol. 2006;45(4):493-7. doi: 10.1080/02841860600604611. Acta Oncol. 2006. PMID: 16760190 No abstract available.
Long-term symptoms after external beam radiation therapy for prostate cancer with three or four fields.
al-Abany M, Helgason AR, Cronqvist AK, Svensson C, Wersäll P, Steineck G. al-Abany M, et al. Acta Oncol. 2002;41(6):532-42. doi: 10.1080/02841860214963. Acta Oncol. 2002. PMID: 12546526
A systematic overview of radiation therapy effects in skeletal metastases.
Falkmer U, Järhult J, Wersäll P, Cavallin-Ståhl E. Falkmer U, et al. Acta Oncol. 2003;42(5-6):620-33. doi: 10.1080/02841860310014895. Acta Oncol. 2003. PMID: 14596519 Review.
Dose to the anal sphincter region and risk of fecal leakage.
al-Abany M, Helgason AR, Cronqvist AK, Lind B, Mavroidis P, Wersäll P, Lind H, Qvanta E, Steineck G. al-Abany M, et al. Acta Oncol. 2004;43(1):117-8. doi: 10.1080/02841860310020933. Acta Oncol. 2004. PMID: 15068331 No abstract available.
Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma.
Wersäll PJ, Blomgren H, Lax I, Kälkner KM, Linder C, Lundell G, Nilsson B, Nilsson S, Näslund I, Pisa P, Svedman C. Wersäll PJ, et al. Radiother Oncol. 2005 Oct;77(1):88-95. doi: 10.1016/j.radonc.2005.03.022. Epub 2005 Jun 20. Radiother Oncol. 2005. PMID: 15972239 Clinical Trial.
A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma.
Svedman C, Sandström P, Pisa P, Blomgren H, Lax I, Kälkner KM, Nilsson S, Wersäll P. Svedman C, et al. Acta Oncol. 2006;45(7):870-5. doi: 10.1080/02841860600954875. Acta Oncol. 2006. PMID: 16982552 Clinical Trial.
Liver, renal, and retroperitoneal tumors: stereotactic radiotherapy.
Kavanagh BD, Scheftera TE, Wersäll PJ. Kavanagh BD, et al. Among authors: wersall pj. Front Radiat Ther Oncol. 2007;40:415-426. doi: 10.1159/000106051. Front Radiat Ther Oncol. 2007. PMID: 17641524 Review.
Temporary effect of arsenic trioxide treatment of refractory extragonadal germ cell cancer.
Kälkner KM, Ullén A, Wersäll P, Cohn-Cedermark G. Kälkner KM, et al. Acta Oncol. 2007;46(6):862-3. doi: 10.1080/02841860601156173. Acta Oncol. 2007. PMID: 17653913 No abstract available.
Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney.
Svedman C, Karlsson K, Rutkowska E, Sandström P, Blomgren H, Lax I, Wersäll P. Svedman C, et al. Acta Oncol. 2008;47(8):1578-83. doi: 10.1080/02841860802123196. Acta Oncol. 2008. PMID: 18607859
Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience.
Lindberg K, Nyman J, Riesenfeld Källskog V, Hoyer M, Lund JÅ, Lax I, Wersäll P, Karlsson K, Friesland S, Lewensohn R. Lindberg K, et al. Acta Oncol. 2015;54(8):1096-104. doi: 10.3109/0284186X.2015.1020966. Epub 2015 Mar 27. Acta Oncol. 2015. PMID: 25813471 Clinical Trial.
Feedback